Avanos Medical, Inc. (AVNS)
Market Cap | 1.47B |
Revenue (ttm) | 795.90M |
Net Income (ttm) | 42.90M |
Shares Out | 46.50M |
EPS (ttm) | 0.90 |
PE Ratio | 35.10 |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 195,347 |
Open | 31.44 |
Previous Close | 31.75 |
Day's Range | 31.43 - 31.89 |
52-Week Range | 19.32 - 35.91 |
Beta | 0.88 |
Analysts | Sell |
Price Target | 28.90 (-8.52%) |
Earnings Date | Feb 22, 2023 |
About AVNS
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 9 analysts, the average rating for AVNS stock is "Sell." The 12-month stock price forecast is $28.9, which is a decrease of -8.52% from the latest price.
News

Avanos Medical, Inc. Announces New Leadership Appointments
ALPHARETTA, Ga. , Jan. 11, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced two executive leadership appointments that support the company's long-term strategic priorities: Micha...

Avanos Medical, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference
ALPHARETTA, Ga. , Jan. 4, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the 41st Annual J.P.

3 Beaten-Down MedTech Stocks Poised for a Turnaround in 2023
Here are some dirt-cheap MedTech value stocks - DYNT, INGN, AVNS - which are expected to provide long-term gains.

3 Reasons to Retain Avanos (AVNS) Stock in Your Portfolio
Investors continue to be optimistic about Avanos (AVNS) owing to its strong product line and focus on R&D.

Avanos Medical (AVNS) Up 21% Since Last Earnings Report: Can It Continue?
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?

Avanos Medical, Inc. Appoints Sudhakar Varshney as Senior Vice President, Global Supply Chain & Procurement
ALPHARETTA, Ga. , Nov. 14, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Sudhakar Varshney has been appointed senior vice president, global supply chain & procurement.

Avanos Medical, Inc. to Present at the Stifel 2022 Healthcare Conference
ALPHARETTA, Ga. , Nov. 8, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, and Michael Greiner, senior vice president and chief financial...

Avanos (AVNS) Q3 Earnings Surpass Estimates, Margins Up
Avanos' (AVNS) third-quarter 2022 results reflect strength in the Pain Management segment.

Avanos Medical (AVNS) Tops Q3 Earnings Estimates
Avanos Medical (AVNS) delivered earnings and revenue surprises of 5.56% and 1.79%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Avanos Medical, Inc. Announces Third Quarter 2022 Results
ALPHARETTA, Ga. , Nov. 2, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported third quarter 2022 financial results.

Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2022 Financial Results
ALPHARETTA, Ga. , Oct. 26, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2022 on We...

Avanos Medical (AVNS) Earnings Expected to Grow: Should You Buy?
Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

New Strong Sell Stocks for October 5th
AVNS, NKE and PLAB have been added to the Zacks Rank #5 (Strong Sell) List on October 5, 2022.

New Strong Sell Stocks for September 28th
AVNS, ARCE and DCO have been added to the Zacks Rank #5 (Strong Sell) List on September 28, 2022.

Avanos Medical (AVNS) Down 14% Since Last Earnings Report: Can It Rebound?
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?

Avanos Medical, Inc. To Present at the Morgan Stanley 20th Annual Global Healthcare Conference
ALPHARETTA, Ga. , Sept. 7, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, and Michael Greiner, senior vice president and chief financia...

7 Safe Small-Cap Stocks to Buy Now
Let's begin by defining the realm of small-cap stocks before we discuss those that appear to be strong, safe investments currently. As their name implies, small-cap stocks have lower market capitaliza...

Avanos (AVNS) Q2 Earnings Top Estimates, FY22 View Lowered
Avanos's (AVNS) second-quarter 2022 results reflect strength in the Pain Management segment.

Avanos Medical (AVNS) Surpasses Q2 Earnings Estimates
Avanos Medical (AVNS) delivered earnings and revenue surprises of 5.13% and 2.47%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Avanos Medical, Inc. Announces Second Quarter 2022 Results
ALPHARETTA, Ga. , Aug. 9, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2022 financial results.

Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2022 Financial Results
ALPHARETTA, Ga. , July 27, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2022 on T...

Avanos Medical (AVNS) to Report Q2 Results: Wall Street Expects Earnings Growth
Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

7 Undervalued Small-Cap Stocks to Buy Now
These undervalued small-cap stocks to buy do have value and could outperform in both the short term and long term. The post 7 Undervalued Small-Cap Stocks to Buy Now appeared first on InvestorPlace.

Can Avanos Medical (AVNS) Keep the Earnings Surprise Streak Alive?
Avanos Medical (AVNS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Here's Why You Should Hold on to Avanos (AVNS) Stock For Now
Investors continue to be optimistic about Avanos (AVNS) owing to its strong product line and focus on R&D.